• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外科经济学:胃肠道出血的成本,识别概念。

Surgonomics: the cost of gastrointestinal hemorrhage, the identifier concept.

作者信息

Muñoz E, Margolis I B, Wise L

出版信息

Am J Gastroenterol. 1985 Feb;80(2):139-42.

PMID:3918438
Abstract

The Tax Equity and Fiscal Responsibility Act will pay hospitals a set price for Medicare patients by one of 467 Diagnostic Related Groups (DRGs). The purpose of this study was to examine one DRG and perform indepth financial analysis in order to develop strategies for cost containment. In addition, we tested the hypothesis that an entity called an identifier (here, the presence or absence of transfusions) could be used to group patients within a specific DRG and demonstrate differences in costs. All patients (n = 46) with gastrointestinal hemorrhage under 70 years old without complications and not requiring surgery (DRG 175) treated at the Long Island Jewish-Hillside Medical Center during 1983 had their hospital charges examined. Total charges (hospital charges exclusive of physician fees) were $3891 +/- 2128 (mean +/- SEM)/patient. Patients requiring transfusion (n = 26) had total charges of $4707 +/- 2292, whereas those not requiring transfusion (n = 20) had total charges of $2765 +/- $1300. Findings in this study are: 1) within a given DRG there is a wide variance of hospital charges, 2) identifiers (in this case transfusion) may be used to clinically aggregate patients with similar resource consumption within a DRG, 3) patients receiving transfusion had 170% greater total charges, 165% greater hematology charges, and 526% greater total blood charges than those not receiving transfusion.

摘要

《税收公平与财政责任法案》将根据467个诊断相关分组(DRG)之一,为医疗保险患者向医院支付固定费用。本研究的目的是检查其中一个DRG并进行深入的财务分析,以制定成本控制策略。此外,我们检验了一个假设,即一种称为标识符(在此为是否接受输血)的因素可用于在特定DRG内对患者进行分组,并证明成本差异。对1983年在长岛犹太-希尔赛德医疗中心接受治疗的所有70岁以下无并发症且无需手术的胃肠道出血患者(n = 46,DRG 175)的医院费用进行了检查。总费用(不包括医生费用的医院收费)为每位患者3891 +/- 2128美元(均值 +/- 标准误)。需要输血的患者(n = 26)总费用为4707 +/- 2292美元,而不需要输血的患者(n = 20)总费用为2765 +/- 1300美元。本研究的结果如下:1)在给定的DRG内,医院收费存在很大差异;2)标识符(在此为输血)可用于在DRG内对资源消耗相似的患者进行临床汇总;3)接受输血的患者总费用比未接受输血的患者高170%,血液学费用高165%,总血液费用高526%。

相似文献

1
Surgonomics: the cost of gastrointestinal hemorrhage, the identifier concept.外科经济学:胃肠道出血的成本,识别概念。
Am J Gastroenterol. 1985 Feb;80(2):139-42.
2
Surgonomics and cost containment.手术经济学与成本控制
Surg Gynecol Obstet. 1986 Feb;162(2):137-41.
3
Do older Medicare patients cost hospitals more? Evidence from an academic medical center.老年医疗保险患者会让医院花费更多吗?来自一家学术医疗中心的证据。
Arch Intern Med. 1993 Jan 11;153(1):89-96.
4
Surgonomics: the identifier concept. Hospital charges in general surgery and surgical specialties under prospective payment systems.外科经济学:标识符概念。前瞻性支付系统下普通外科和外科专科的医院收费。
Ann Surg. 1985 Jul;202(1):119-25. doi: 10.1097/00000658-198507000-00019.
5
The identifier concept: clinical parameters to stratify hospital costs within gastroenterology DRGs.标识符概念:用于在胃肠病学诊断相关分组(DRGs)中对医院成本进行分层的临床参数。
Am J Gastroenterol. 1987 Dec;82(12):1250-5.
6
The identifier concept: clinical variables to manage costs for surgical patients.标识符概念:用于管理外科患者成本的临床变量。
Hosp Health Serv Adm. 1987 Feb;32(1):85-96.
7
The identifier concept: clinical parameters to stratify hospital patient costs for patients with hypertension.
Heart Lung. 1988 Sep;17(5):550-4.
8
Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.胸主动脉瘤修复术。直接住院费用及诊断相关分组报销。
Scand Cardiovasc J. 2008 Feb;42(1):77-84. doi: 10.1080/14017430701716814.
9
Analysis of nationwide pharmacy charges per DRG.按疾病诊断相关分组(DRG)分析全国药房收费情况。
Am J Hosp Pharm. 1985 Oct;42(10):2168-74.
10
ABC analysis of the relationship between pharmacy charges and DRGs.
Am J Hosp Pharm. 1985 Mar;42(3):571-6.

引用本文的文献

1
An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failures.评估活化蛋白C相对于器官系统衰竭数量的成本效益。
Pharmacoeconomics. 2003;21(18):1331-40. doi: 10.1007/BF03262331.
2
Postoperative stay associated with prognosis of patients with colorectal cancer.术后住院时间与结直肠癌患者的预后相关。
Ann Surg. 1996 Apr;223(4):351-6. doi: 10.1097/00000658-199604000-00002.